Equity · Healthcare
TECX
NASDAQTectonic Therapeutic (TECX)
This price chart is drawn by TradingView, from their own data, in an embed loaded from their servers.
- Market cap
- 658.3M USD
- EPS, diluted, year to Dec 2025
- −4.05 USD
- 52-week range
- 14.73 USD – 38 USD
- Avg volume
- 42.9K
as of Jul 17, 2026
Have Tectonic Therapeutic (TECX) insiders bought or sold shares recently?
In the 90 days to 22 Nov 2026, Tectonic Therapeutic insiders reported 2 open-market sales and no purchases (SEC Form 4); none has bought on the open market since 11 Feb 2026.
Form 4, 90 days to 22 Nov 2026, newest reported trade 30 Sep 2026
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 30 Sep 2026 | McNamara PeterChief Scientific Officer | Sell | 536 | 12K USD |
| 25 Aug 2026 | McNamara PeterChief Scientific Officer | Sell | 43 | 2K USD |
| Sold | 2 open-market sales | 579 | $14K |
7 other filings in the window: grants, exercises, tax withholding and transfers, not trades
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 26 Oct 2026 | REICIN ALISEChief Executive Officer | Option exercise | 10,000 | 24K USD |
| 25 Sep 2026 | Lochner DanielChief Financial Officer | Tax withheld | 520 | 12K USD |
| 25 Sep 2026 | McNamara PeterChief Scientific Officer | Tax withheld | 444 | 11K USD |
| 25 Sep 2026 | REICIN ALISEChief Executive Officer | Tax withheld | 1,545 | 37K USD |
| 25 Sep 2026 | Ruddy Marcella K.Chief Medical Officer | Tax withheld | 525 | 12K USD |
| 25 Sep 2026 | Schwabish MarcChief Business Officer | Tax withheld | 411 | 10K USD |
| 25 Aug 2026 | McNamara PeterChief Scientific Officer | Option exercise | 43 | 633 USD |
Which funds hold Tectonic Therapeutic (TECX)?
7 of the 45 institutional funds we track reported a Tectonic Therapeutic position for the quarter ended 30 Sep 2026 — a combined 38.8M USD; the latest of those filings landed 16 Nov 2026.
| Fund | Position | Shares | Value | Shares q/q |
|---|---|---|---|---|
| Baker Bros. Advisors | Held (±25%) | 607,788 | 14.2M USD | |
| Marshall Wace | Added | 446,511 | 10.4M USD | +159.4% |
| Citadel Advisors | Added | 193,039 | 4.5M USD | +113.6% |
| D. E. Shaw & Co. | Held (±25%) | 182,528 | 4.3M USD | −2.2% |
| Millennium Management | Held (±25%) | 126,963 | 3.0M USD | −23.3% |
| Balyasny Asset Management | New position | 91,096 | 2.1M USD | |
| Fisher Asset Management | Held (±25%) | 19,122 | 445K USD | |
| AQR Capital Management | Exited |
What has been filed or recorded for Tectonic Therapeutic (TECX)?
The filings we hold for Tectonic Therapeutic, newest first: 2 fails-to-deliver days, 6 quarterly earnings reports, 2 annual reports and 4 reported financial figures, the latest dated 28 Oct 2026. No next earnings date is announced in SEC filings yet.
| And | ||||
|---|---|---|---|---|
| 28 Oct 2026 | Fails to deliver | Shares failed to deliver | 1,049 shares | 21K USD notional · 0.005% of shares out |
| 26 Oct 2026 | Fails to deliver | Shares failed to deliver | 4,969 shares | 100K USD notional · 0.025% of shares out |
| 30 Sep 2026 | Quarterly earnings | Q3 2026 reported | EPS −1.08 USD | |
| 30 Sep 2026 | Financials | Total assets | 243.9M USD | at period end |
| 30 Sep 2026 | Financials | Total equity | 229.3M USD | at period end |
| 30 Jun 2026 | Quarterly earnings | Q2 2026 reported | EPS −1.18 USD | |
| 31 Mar 2026 | Quarterly earnings | Q1 2026 reported | EPS −1.34 USD | |
| 31 Dec 2025 | Annual report | FY 2025 reported | EPS −4.05 USD | |
| 31 Dec 2025 | Financials | Net income | −74.2M USD | fiscal year |
| 31 Dec 2025 | Financials | Diluted EPS | −4.05 USD | fiscal year |
| 30 Sep 2025 | Quarterly earnings | Q3 2025 reported | EPS −1.02 USD | |
| 30 Jun 2025 | Quarterly earnings | Q2 2025 reported | EPS −1.07 USD | |
| 31 Mar 2025 | Quarterly earnings | Q1 2025 reported | EPS −0.93 USD | |
| 31 Dec 2024 | Annual report | FY 2024 reported | EPS −6.83 USD |
What do people ask about Tectonic Therapeutic (TECX)?
What is Tectonic Therapeutic’s market cap?658.3M
Tectonic Therapeutic is worth 658.3M USD by market value as of 17 Jul 2026, which is the share price times the shares on issue from its SEC filings.
Have Tectonic Therapeutic insiders bought or sold shares recently?2 sales
In the 90 days to 22 Nov 2026, Tectonic Therapeutic insiders reported 2 open-market sales and no purchases (SEC Form 4); none has bought on the open market since 11 Feb 2026. A further 7 filings were grants, awards, gifts or exercises rather than open-market trades. See Insiders
Which funds own Tectonic Therapeutic?7 of 45
7 of the 45 funds we track reported a Tectonic Therapeutic position for the quarter ended 30 Sep 2026, per their SEC Form 13F filings. The largest reported positions were Baker Bros. Advisors, Marshall Wace and Citadel Advisors. See Funds
When did Tectonic Therapeutic last report earnings?−1.08
Tectonic Therapeutic last reported earnings on 30 Sep 2026 for Q3 2026, with EPS of −1.08 USD; no next date is announced in SEC filings yet. See Filings

Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.
References
- Finazonprior-day close, indicative (IEX-derived, not the official close)
- TradingViewthe price chart widget, drawn by TradingView from their own data
- SEC EDGARForm 4 filings (insider transactions)
- SEC EDGAR13F filings
- SECSEC fails-to-deliver (CNS) data
- SEC EDGARXBRL company facts, latest period ended 30 Sep 2026
- SEC EDGARreported earnings figures and scheduled report dates
- SEC EDGARValuation computed from SEC EDGAR filings
- SEC filingAbout text: the company's latest annual report filed with the SEC (Business section), summarised in our own words